晚期甲状腺癌患者的症状集群:一个横截面研究
1Division of Thyroid Surgery, Department of General Surgery, West China Hospital, Sichuan University, Chengdu, 610041, China. caiming826@126.com.
Endocrine
|September 25, 2024
概括
晚期甲状腺癌患者经历了显著的症状集群,影响日常生活. 识别这些集群,如情绪-疲劳-睡眠,有助于有针对性的症状管理,并改善患者的护理.
科学领域:
- 在瘤学瘤学.
- 症状科学 症状科学
- 患者护理 患者护理
背景情况:
- 晚期甲状腺癌具有复杂的症状负担.
- 有效的症状管理对于患者的生活质量至关重要.
研究的目的:
- 在晚期甲状腺癌患者中识别和分析症状集群.
- 为有针对性的症状管理策略奠定基础.
主要方法:
- 晚期甲状腺癌患者的横截面调查 (2022年4月至2023年4月).
- 使用了医疗保健. 安德森的症状库存-甲状腺癌模块 (MDASI-THY).
- 探索性因子分析被用来提取症状集群.
主要成果:
- 睡眠障碍 (75.7%的发病率) 和情绪困扰 (63.5%的发病率) 非常普遍.
- 鉴定了三个不同的症状集群:情绪疲劳睡眠,消化道感觉和甲状腺癌特异性症状.
- 症状严重程度和干扰在集群中各不相同,严重影响患者的日常生活.
结论:
- 晚期甲状腺癌与多种,具有影响力的症状集群有关.
- 医疗保健专业人员的有针对性的观察和预防性干预是必不可少的.
- 减少症状负担可以显著改善晚期甲状腺癌患者的健康状况.
更多相关视频
04:01Transoral Robotic Total Thyroidectomy and Bilateral Central Regional Lymph Node Dissection for Papillary Thyroid Carcinoma
Published on: September 15, 2023
740
05:41Author Spotlight: Integrating Ultrasound Imaging with Biochemical Markers for Thyroid Disease Diagnosis
Published on: February 9, 2024
552
相关概念视频
Aneurysm II: Clinical Manifestations and Diagnostic Studies
589
Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
589
Hyperthyroidism I: Introduction
30
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
30
Hyperthyroidism II: Pathophysiology
28
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH...
28
Graves' Disease I: Introduction
23
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence...
23
Graves Disease II: Pathophysiology
26
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor,...
26
Goiter
32
Goiter refers to an abnormal enlargement of the thyroid gland that may appear as a diffuse goiter (uniform enlargement) or nodular (single or multiple nodules). Functionally, it is classified as nontoxic (normal/low hormone levels) or toxic (excess hormone production).PathophysiologyDiffuse thyroid enlargement typically results from prolonged stimulation by thyroid-stimulating hormone (TSH) or TSH-like agents, commonly seen in hypothyroidism or iodine deficiency. In contrast, in hyperthyroid...
32
